The risk of death due to liver disease is twice as high for patients with chronic hepatitis B infection compared to individuals with chronic hepatitis C, US researchers report in the online edition of Clinical Infectious Diseases.
The study involved gay and other men who have sex with men, most of whom were HIV positive. Hepatitis B remained associated with a two-fold increase in the risk of liver-related death when analysis was restricted to HIV-positive individuals. The risk of liver-related mortality was especially high for people with a low CD4 cell count.
The Food and Drug Administration warned Friday that doctors should not prescribe and patients should not use the hepatitis C drug Victrelis (boceprevir) and the anti-HIV drug ritonavir at the same time because such use reduces the effectiveness of both drugs.
Three cases of acute pancreatitis, one fatal, have led the FDA to put a clinical hold on a trial of an investigational oral drug for hepatitis C called alisporivir, according to the product’s manufacturer.
An official at Novartis broke the news at a press conference held Thursday at the European Association for the Study of the Liver meeting in Barcelona. Read more here.
“‘The only appropriate motivation should be what is the best and fastest way to get cures, not what is best for the shareholders,’ said Dr. Scott Friedman, chief of liver diseases at the Mount Sinai School of Medicine in New York…” Read more here.
“Imagine my excitement when the individual local grassroots hep B campaigns from around the U.S. came together and decided to form a national coalition—Hep B United (the Philadelphia campaign becomes Hep B United Philadelphia). Having a formal national coalition will help local campaigns to become more versatile and more effective, both collectively and individually… they will be able to work with federal and national partners without losing touch with the local campaigns. A unified national presence and identity will also strengthen the ongoing advocacy work to raise awareness among policy makers… Ultimately, all of these benefits will help us better serve our communities.”—
Daniel Chen from the Hepatitis B Foundation has written a great blog post announcing that the local Hep B Free campaign has changed its name to Hep B United Philadelphia. This will bring hep B coalitions across the country together under a united network. We look forward to seeing what exciting work can be accomplished with our national partners!
Visit this website to see where you can return unused prescription drugs on 4/28. National Prescription Drug Take Back Day addresses a vital public safety and public health issue. More than seven million Americans currently abuse prescription drugs, according to the 2009 Substance Abuse and Mental Health Services Administration’s National Survey on Drug Use and Health. Each day, approximately, 2,500 teens use prescription drugs to get high for the first time according to the Partnership for a Drug Free America.
Prescription drug use can lead to injecting drugs - disposing of unused or wanted medications can help reduce drug use and therefore helps prevent hepatitis C!
This blog post by Dr. Ron Valdiserri, who is Director of HHS’ Office of HIV Planning and Infectious Disease Policy, summarizes highlights from a recent day-long consultation about hepatitis testing. Several programs initiated by Adult Viral Hepatitis Prevention Coordinators across the country are highlighted!